Wolverine Trading’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-43,200
Closed -$594K 5912
2025
Q2
$594K Buy
43,200
+24,400
+130% +$230K ﹤0.01% 2786
2025
Q1
$102K Buy
18,800
+8,200
+77% +$46.5K ﹤0.01% 4214
2024
Q4
$54.3K Sell
10,600
-8,300
-44% -$43.5K ﹤0.01% 4968
2024
Q3
$98.5K Buy
+18,900
New +$109K ﹤0.01% 4360
2022
Q4
Sell
-10,900
Closed -$23K 4563
2022
Q3
$23K Buy
+10,900
New +$26K ﹤0.01% 4356
2022
Q1
Sell
-10,600
Closed -$43K 5984
2021
Q4
$43K Sell
10,600
-9,600
-48% -$45.4K ﹤0.01% 5363
2021
Q3
$122K Sell
20,200
-96,200
-83% -$821K ﹤0.01% 5667
2021
Q2
$1.35M Buy
116,400
+70,000
+151% +$805K ﹤0.01% 2444
2021
Q1
$741K Buy
+46,400
New +$835K ﹤0.01% 3155

Other funds holding LFMD

Wolverine Trading's LFMD Position: Q3 2025 in Review

Wolverine Trading sold out of LifeMD (LFMD) in Q3 2025, closing a stake of 74,289 shares — an estimated $1.02M sold.

Wolverine Trading first reported a position in LFMD in Q1 2021 and held it in 7 quarters. The position peaked at $1.02M in Q2 2025. 114 funds tracked by Wall St. Rank hold LFMD as of Q3 2025.

  • Wolverine Trading reported no remaining LifeMD position as of Q3 2025 after selling out during the quarter.
  • Wolverine Trading sold 74,289 LifeMD shares in Q3 2025, an estimated $1.02M.
  • Wolverine Trading first reported a position in LifeMD in Q1 2021 and held it in 7 quarters.
  • Wolverine Trading's LifeMD position peaked at $1.02M in Q2 2025.
  • 114 funds tracked by Wall St. Rank held LifeMD as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.